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ABSTRACT
Development of methods that will allow exogenous
imposition of inheritable gene-specific methylation
patterns has potential application in both therapeu-
tics and in basic research. An ongoing approach is
the use of targeted DNA methyltransferases, which
consist of a fusion between gene-targeted zinc-
finger proteins and prokaryotic DNA cytosine
methyltransferases. These enzymes however have
so far demonstrated significant and unacceptable
levels of non-targeted methylation. We now report
the development of second-generation targeted
methyltransferase enzymes comprising enhanced
zinc-finger arrays coupled to methyltransferase
mutants that are functionally dominated by their
zinc-finger component. Both in vitro plasmid methy-
lation studies and a novel bacterial assay reveal a
high degree of target-specific methylation by these
enzymes. Furthermore, we demonstrate for the first
time transient expression of targeted cytosine
methyltransferase in mammalian cells resulting in
the specific methylation of a chromosomal locus.
Importantly, the resultant methylation pattern is
inherited through successive cell divisions.
INTRODUCTION
The link between DNA methylation and gene expression has
come under intense scrutiny over recent years and a number
of groundbreaking discoveries have been made, linking DNA
methylation, histone methylation and/or deacetylation to the
formation or modulation of higher order, repressive chro-
matin structures through various protein–DNA interactions
(1–5). Moreover, high levels of DNA methylation are often
found in the promoters of transcriptionally silent genes, espe-
cially in cancer. Such observations have led to the proposition
that methylation is a key mechanism for controlling gene
expression in the cell. The ability to impose DNA methyla-
tion at speciﬁc sites in the genome as a potential means of
controlling heritable gene expression for both therapeutic
and research applications is therefore a desirable goal.
Whether methylation is the cause or consequence of
transcriptional silencing in all cases is still unclear. This is
largely because it has not been possible to investigate the
effects of de novo methylation in the cell as it occurs or simu-
late it in a meaningful way and much of our understanding of
this epigenetic process therefore comes from post-event
observations. Attempts to examine the consequences of
de novo methylation on gene expression, methylation spread
and transcriptional elongation have mainly involved transient
transfection of in vitro methylated reporter constructs or,
more elegantly, by Cre/LoxP-mediated genomic placement
of in vitro methylated DNA (6). Even the latter approach
however is imperfect, since it cannot divorce methylation
mediated effects from the action of the integration/repair
processes involved in DNA placement. Reports have
described the use of siRNA targeted to the EF1A, erbB2,
IL-2 and E Cadherin promoters, which resulted in the local-
ized methylation and transcriptional down regulation of the
gene promoters (7–9). Recruitment of DNA or histone
methyltransferases to target loci via siRNA interaction with
DNA or nascent transcripts are two postulated routes by
which this effect may occur. However, the exact mechanism
by which this effect is implemented remains unclear at
present, as does the global applicability of this approach,
since other studies have failed to detect similar RNA-directed
methylation of targeted genes (10,11). Moreover, additional
evidence suggests that short double-stranded RNA can induce
transcriptional silencing in the absence of DNA methylation
(12). The targeted methylation of the GSTP1 and IGF2
promoters using single-stranded methylated oligodeoxynu-
cleotides complementary to those promoter regions has also
been reported, although again the mechanism remains unclear
(13,14). Given the sporadic outcome of these methodologies,
their application in the generation of targeted methylation
currently appears limited.
A more robust approach to delivering targeted cytosine
methylation is the use of site-biased DNA methyltransferase
(Mtase) enzymes, which potentially can deliver both CpG
and non-CpG methylation directly at the target locus. The
use of zinc ﬁngers as the targeting component for a number
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described, allowing the progression of this class of molecule
into the therapeutic arena (15). The ﬁrst report of a targeted
Mtase enzyme described a fusion between the CpG-speciﬁc
Mtase M.SssI and the Zif268 three zinc-ﬁnger protein or a
three zinc-ﬁnger protein speciﬁc for the p53-binding site
found in the p21
WAF/CIP1 gene (16). When similar enzymes
were recently assayed in a yeast model, although enhanced
methylation was observed at the target region, levels of
CpG methylation at non-targeted sites were equivalent to
those obtained using non-targeted wild-type Mtase enzyme
(17). We have also similarly shown that other CpG Mtases
can be targeted to speciﬁc sites on DNA, but that non-speciﬁc
methylation is still a signiﬁcant problem (18).
We now report the construction and evaluation of targeted
Mtases with substantially enhanced targeted methylation
properties. Using rational mutagenesis we have modiﬁed
the catalytic/binding attributes of the Mtase components of
two different targeted Mtases, M.HpaII and M.HhaI. These
enzymes recognize the sequences 50-CCGG-30 and 50-GCGC-
30, respectively, and the core methylation site is the cytosine
in the sequence 50-CpG-30. We demonstrate that these
enzymes are highly site-speciﬁc, producing a signiﬁcantly
reduced background methylation in the absence of a tar-
getable site, in comparison with targeted wild-type enzymes.
Expression of a targeted HpaII enzyme in mammalian cells
results in speciﬁc de novo methylation of a target locus.
The persistence of the methylation pattern over time shows
that the de novo methylation pattern is inherited through
successive cell divisions. Furthermore, the de novo methyla-
tion remains conﬁned to the initial target region with little
observable spread to ﬂanking regions.
MATERIALS AND METHODS
Constructs
The pGex vector pG4Zf harbouring a four zinc-ﬁnger protein
(4aZf) recognizing the sequence 50-GACGCAGAAGCC-30 has
been described previously (19). The four zinc-ﬁnger coding
DNA fragment was excised from this vector via NdeI
and BamHI digestion and cloned into pG3ZfHhaI and
pG3ZfHpaII vectors [harbouring three zinc-ﬁnger HhaI or
HpaII wild-type and mutant fusion sequences, which have
been described previously (18)], which had been similarly
restricted, thus replacing the original three zinc-ﬁnger
sequence. Gene sequences coding for the four zinc-ﬁnger
Mtase fusion proteins were cloned into the modiﬁed pLysE
vector described below, as NdeI/NotI fragments. The four
zinc-ﬁnger gene for the protein 4bZf, designed to recognize
the target sequence 50-GACGCGGCGCTC-30, was con-
structed using published zinc-ﬁnger recognition codes and
assembled directly via ligation of oligonucleotides coding
for each individual zinc-ﬁnger sequence. The recognition
code (a-helical residues  1, 1, 2, 3, 4, 5, 6) used was
ASDDLTQ (CTC subsite), RSDDLQR (GCG) and
DRSNLTR (GAC). The four zinc-ﬁnger gene coding for
the 4cZf protein was designed to recognize the sequence;
50-TGGGGAGTGGCG-30, and was similarly constructed
[RSDELTR (GCG), RSDALSR (GTG), DSAHLTR (GGA)
and RSDHLST (TGG)]. The zinc-ﬁnger backbone sequence
used was that described for the anti-p190BcrAbl 3Zf protein
(20). A six zinc-ﬁnger gene coding for two repeats of the
zif268 three zinc-ﬁnger gene was constructed by ligation of
two PCR products, each coding for one set of three zinc ﬁn-
gers, using the following primers: primers used were 1A and
1B for one PCR; 50-gcgccagatcttggaacgcccatatgcttgccctgtcga-
gtcctg-30,5 0-gcgcggatccgcccccgtccttctgtcttaaatggattttggtatgc-
ctcttgcgtt-30, and primers 2A and 2B for the second PCR;
50-gcgcgagatctgaacgcccatatgcttgccctgtcgagtcctgcgat-30 and 50-
gcgcggatccgtccttctgtcttaaatggattttggtatgcc-30. PCR products
were restricted with BamHI and BglII and sequentially
cloned into BamHI restricted pGex4T-1 vector (Amersham
Biosciences). The assembled six zinc-ﬁnger gene was PCR
ampliﬁed from this vector using primer 1B above, and primer
6R 50-gcgcattaatggatctgatcgaaggtcgtgggatcttggaa-30,r e s t r i c t e d
with BamHI and AseI (underlined in the above sequences)
and ligated onto the modiﬁed pLysE vectors described
below, replacing the existing zinc-ﬁnger gene sequences
present in targeted methylase constructs, excised as NdeI/
BamHI fragments.
Mutagenesis of Mtase enzymes was carried out using the
‘quickchange’ protocol (Stratagene, CA) according to the
manufacturer’s instructions, using pGex-based clones as tem-
plates. Primers for mutagenesis were supplied by MWG (Ger-
many) or Sigma (UK) and were gel puriﬁed before use.
Primer sequences (only one strand is given) were as follows:
HhaI-null mutant (stop codon introduced), 50-ggaaaacaaaaag-
gattctagaacagcagaggtacgctc-30; HhaI R(165)G, 50-gaaaacaaat-
catatagatcccttcccttttctgtg-30; HhaI Q(237)G, 50-cttggtattgtagg-
aaaaggtgggggcggagaacgaatttatagtactagaggcattgca-30; HhaI
Q(237)V, 50-cttggtattgtaggaaaaggtggggtgggagaacgaatttatagta-
ctagaggcattgca-30; HhaI Q(237)I, 50-cttggtattgtaggaaaaggtgg-
gatcggagaacgaatttatagtactagaggcattgca-30; HhaI Q(237)E, 50-
cttggtattgtaggaaaaggtggggaaggagaacgaatttatagtactagaggcat-
tgca-30; HpaII F(38)H, 50-tttacttttatcgatttacatgcaggtattggtgga-
30 and HpaII R(189)G, 50-ccacaaaatagagaagggatctatattgtaggc-
ttt-30. The HpaII-null construct was obtained by restriction of
wild-type vector with MunI, followed by ﬁlling in the over-
hangs and religating the vector, thus generating a frameshift
within the Mtase coding sequence.
Targetsitevectorswereconstructedinthefollowingmanner.
Annealed oligonucleotides (with single A-base overhangs)
harbouring single HpaII and HhaI sites (boldface) and ﬂanked
by the 6a and 4a zinc-ﬁnger recognition sites (underlined)
(50-agttccgcccacgctcgcccacgctacgctcttaaccggcgcctggttaggctg-
tgggacgcagaagcctcctc-30) or by the 4c and 4b zinc-ﬁnger
recognition sites, respectively (50-tggccacgccactccccaggctcc-
attccaggccggcgcaatgctagactcgacgcggcgctcgttgcca-30) were clo-
ned directly into pTopo2.1. These oligonucleotides (desig-
nated Ta and Tb/c, respectively) were also used as probes
in band shift assays. These vectors were used directly in
in vitro methylation assays. The insert and ﬂanking sequence
were then ampliﬁed by PCR using the speciﬁc primers
described below and cloned back into pTopo2.1. Primer
sequences used to generate the HpaII target site vector were
50-gtatgttgtgtggaattgtgagcggat-30 and 50-ggcgcagcggtcgggctg-
aacgggggg-30; and to generate the HhaI target site vector
were 50-cgcaattaatgtgagttagctcactcatta-30 and 50-ctgttgggaag-
ggcgatcggtgcgggcctc-30. These plasmids were used in
bacterial-based assays. DNA fragments generated by this
PCR were also used in initial methyltransferases assays and
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zinc-ﬁnger recognition sites they contained in the context of
the assay being performed.
Vectors expressing targeted Mtase enzymes for in situ
methyltransferase speciﬁcity analysis were based on the
pLysE vector (Novagen), harbouring a pTac promoter. The
complementary oligonucleotides: (50–30) gatctgttgacaattaat-
catcggctcgtataatgtgtggaattgtgagcggataacaatttcacatatgctaaagc-
tttgagcggccgctag; agctctagcggccgctcaaagctttagcatatgtgaaattg-
ttatccgctcacaattccacacattatacgagccgatgattaattgtcaaca, were an-
nealed generating BamHI and HindIII overhangs, and ligated
into the appropriate restriction sites in pLysE vector. Internal
NdeI and NotI sites are underlined and were used for subse-
quently cloning genes for zinc-ﬁnger–Mtase fusion proteins
into the modiﬁed pLysE expression vector, from pGex
vectors described previously. Target site vector (Targ1)
for mammalian experiments was made by oligonucleotide
insertion into the HindIII site of pBLB-Bcr-Abl (21). Tar-
geted methyltransferases were expressed in mammalian
cells from the CMV promoter, as fusions with the SV40
nuclear localization sequence and the FLAG epitope tag
using the pFLAG CMV-2 vector (Sigma), the latter was
used for protein detection in western analysis.
Reagents
Restriction enzymes, T4 ligase, T4 kinase and high-purity
dNTPs were purchased from NEB (UK). General chemicals
were from Sigma. Taq polymerase was from Promega,
poly(dI)–(dC) from Pharmacia Biotech and [g-
32P]ATP
(>11 TBq/mmol) was purchased from ICN.
Cell culture
HeLa cells were grown in DMEM supplemented with 10%
foetal calf serum. All transfections were performed according
to the BES CaPO4 method (22). Stable cell lines were gener-
ated by co-transfection of the Targ1 target site vector and a
vector that expressing puromycin at a ratio of 10:1, respec-
tively, using a total of 3 mg DNA on cells seeded at 5 ·
10
5 cells per 5 cm dish. Single clonal colonies were assessed
for reporter gene expression. One clone was chosen for
further transfection studies for which Southern blot analysis
indicated as having a single integration event. This target
clonal cell line was co-transfected with expression or control
vectors, together with a vector expressing the low density
truncated nerve growth factor receptor (LNGFR) at a ratio of
4:1, using 8 mg of methylase expression vector and a total of
12 mg DNA on 2 · 10
6 cells. After 72 h, cells were isolated
by afﬁnity capture using anti-LNGFR-biotin/streptavidin
coupled magnetic beads (Dynal) according to the manufac-
turer’s instructions. This was done to enhance the ratio of
transfected to non-transfected cells, with respect to methyl-
transferase expression vectors, in order to assist downstream
DNA methylation analysis. For expression studies, equivalent
transfections were performed and RNA or protein was
collected downstream.
DNA-binding and methylation assays
Escherichia coli ER1647 [F
  fhuA2 D(lacZ)rl supE44 trp31
mcrA1272::Tn10(Tet
r) his-1 rpsL104(Str
r) xyl-7 mtl-2
metB1 D(mcrC-mrr)102::Tn10(Tet
r) recD1014] was used
for the expression of GST–four zinc ﬁnger HpaII and GST-
HpaII fusion proteins. Protein puriﬁcation and EMSA anal-
ysis were performed as described previously (18,19). Protein
concentrations were quantiﬁed and balanced against a known
BSA standard after separation by SDS–PAGE and gel stain-
ing with coumassie blue. Apparent dissociation constants
were determined from protein titration EMSAs, and were
calculated as the protein concentration at 50% DNA–protein
complex formation using Graphpad Prizm software, essen-
tially as described previously (18). In vitro plasmid methyla-
tion assays involved incubation of puriﬁed protein with
plasmid in binding buffer (20 mM HEPES, pH 7.5, 1 mM
dithiothreitol, 20 mM ZnSO4, 5 mM MgCl2, 50 mM KCl,
5% glycerol, 0.1% NP-40 and 0.1 mg/ml BSA) containing
100 mM S-adenosylmethionine for 1 h at 37 C. The reaction
was stopped by heating at 80 C for 20 min and then digested
with 20 U of HpaII restriction enzyme overnight at 37 C.
Products were analysed on a 2% agarose gel run in TBE
buffer.
Bacterial ‘in situ’ targeted methylation assay
E.coli Top10 cells (Invitrogen) [F
  mcrA D(mrr-hsdsRMS-
mcrBC) j80lacZDM15 DlacX74 recA1 araD139 D(ara-
leu)7696 galU galK rpsL (str
r) endA1 nupG] were transformed
with combinations of relevant target and expression vectors.
Colonies were grown overnight in the presence of ampicillin
and chloramphenicol and plasmids subsequently isolated by
standard alkaline lysis methodology (22) and subjected to
restriction with the relevant restriction enzymes. Restriction
products were analysed by agarose gel electrophoresis.
Arbitrary primed PCR analysis
Genomic DNA (2 mg) was isolated from E.coli expressing
targeted HpaII or HhaI methyltransferase enzymes or from
untransformed E.coli using GenElute bacterial genomic
DNA isolation kit (Sigma), and subjected to overnight diges-
tion with >30 U of relevant restriction enzyme. After heat
killing the enzyme at 70 C for 20 min and visually conﬁrm-
ing the digestion of genomic DNA, 200 ng of the digest
was used in a PCR employing the following primer sequences
(50–30): tggccgccga, ntgggcggga, ctgacgttg, attgtgcttg.
Cycling conditions were as follows: 95 C for 30 s, 35 C
for 2 min, 72 C for 2 min, for 40 cycles, after an initial
pre-melt incubation at 95 C for 2 min. Products were anal-
ysed on a 4% acrylamide–8 M urea gel and visualized by
staining with Sybr green (Sigma). Differences in methylation
between genomic samples were interpreted both from the
relative intensities and band distribution of the resultant
PCR proﬁles.
RT–PCR
RNA was extracted using the Trizol methodology (Invitro-
gen) according to the manufacturer’s instructions. Poly(A)
RNA was isolated using ‘Micro to Midi’ columns (Invitro-
gen) and cDNA generated using the ‘Cloned AMV ﬁrst strand
synthesis kit’ (Invitrogen) according to the manufacturer’s
instructions. PCR was performed using the following
parameters: 94 C 30s, 55 C 30s, 72 C 45s for increasing
cycle numbers. Primers used were either speciﬁc for the tar-
geted Mtase gene (50-CTTACCTGTAGCTTGAATAGCC-30;
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gene (50-GTGGGCCGCTCTAGGCACCAA-30;5 0-CTCTTT-
GATGTCACGCACGATTTC-30). PCR products were anal-
ysed on a 1% agarose gel.
Bisulphite sequencing
Genomic DNA isolated from HeLa cells was subjected to
bisulphite modiﬁcation using the CpGenome kit (Chemicon)
according to the manufacturer’s instructions. Primers used for
1st and 2nd round PCR, designed to amplify modiﬁed DNA
and sequence the top strand, but were not biased towards
methylation, have the following sequence: 1st round forward
50-ggtattagagtagattgtattgagagtg-30, reverse 50-ctatcccatatcacc-
aactcaccatctttc-30; 2nd round forward 50-ggatgtgttgtaagg(c/
t)gattaagttggg-30, reverse 50-caactaactaaaatacctcaaaatattc-30.
PCR products were cloned into PCRTopo2.1 cloning vector
(Invitrogen). Only sequences shown to be converted (>90%,
based on relative numbers of unconverted Cs in the context
of non-CpG sequences) were used in subsequent analysis
of methylation status. Sequencing was carried out by Lark
Technologies (UK) and MRC Geneservice (UK).
RESULTS
We have previously shown that three zinc-ﬁnger–HpaII and
HhaI wild-type enzymes bind preferentially in vitro to a
target site composed of adjacent zinc-ﬁnger and Mtase recog-
nition sites. However, these enzymes also displayed signiﬁcant
non-speciﬁc methyltransferase activity, not immediately appar-
ent in in vitro studies, but noticeable when these enzymes
were expressed in E.coli (18). Previously we have demon-
strated enhanced binding attributes of an array-extended
four zinc-ﬁnger derivative (henceforth designated 4a) of the
progenitor three zinc-ﬁnger protein component of this
enzyme, which recognizes the sequence 50-GACGCAGAAG-
CC-30 (19,21). We therefore initially examined whether this
four zinc-ﬁnger component would enhance targeted methyla-
tion by wild-type Mtase enzymes and reduce non-speciﬁc
background methylation. An initial assay of the 4aWT
HpaII and 4aWT HhaI Mtase enzymes reveal that the coding
vectors are methylated when isolated from bacteria, as judged
by insensitivity to HpaII or HhaI restriction, respectively
(Figure 1A, left-hand side of each panel), despite having no
zinc-ﬁnger recognition site within the plasmid sequences.
Mutagenesis and zinc-finger arrays
In order to overcome the high levels of non-targeted methy-
lation observed for wild-type-based enzymes generally, we
introduced mutations to the Mtase component of the fusion
enzymes. The rationale for this was that either a reduction
of the catalytic activity or binding afﬁnity of the Mtase
component would allow the zinc-ﬁnger component to domi-
nate protein–DNA interactions, giving lower levels of back-
ground (non-targeted) methylation. A highly conserved
sequence homology exists between cytosine 5-Mtases,
located within 10 speciﬁc homology blocks (23) and the
contributions made by these conserved elements have been
largely elucidated, especially for the HhaI Mtase (24–29).
For example, F
18 in the conserved element F
18xGxG in
M.HhaI helps to position the adenine ring of the co-factor
S-adenosylmethionine in the protein binding pocket, while
residue Q
237, which surprisingly is not conserved between
cytosine Mtases, helps to stabilize the protein–DNA structure
by taking the place of the extruded cytosine base. Such
mutational analyses have provided the basis of a rational
mutagenesis approach for the enhancement of targeted
Mtase function, focused predominantly on targeted HpaII
F
35H (corresponding to F
18 in HhaI) and HhaIQ
237 to glycine
(G), valine (V) and isoleucine (I) mutant Mtase enzymes.
An initial assessment of the plasmids coding for the
4aF
35H HpaII (henceforth referred to as 4aFH) and
4aQ
237G HhaI (henceforth referred to as 4aQG) Mtase pro-
teins revealed that they were digested completely by HpaII
and HhaI restriction enzymes, respectively, giving patterns
similar to plasmids coding for null activity enzymes
(Figure 1A). This was therefore in stark contrast to the
respective targeted wild-type enzymes and provided an initial
indication that mutant enzymes were not functional in the
absence of a zinc-ﬁnger recognition site. In addition to
mutagenesis of the Mtase component, two additional four
zinc-ﬁnger proteins and a six zinc-ﬁnger protein were con-
structed with varying speciﬁcities, designed using published
Figure 1. (A) Methylation sensitive restriction analysis of expression
plasmids coding for wild-type and mutant targeted methyltransferases.
Expression plasmids coding for 4aWT, 4aFH and 4aNull HpaII based
enzymes and 4aWT, 4aQG and 4aNull HhaI based enzymes were isolated
from E.coli and subjected to restriction with methylation sensitive and/or
insensitive isoschizomer restriction enzymes (left and right panels). The
middle panel shows methylation-sensitive restriction digestion of higher copy
number GST fusion expression plasmids coding for HpaII wild-type and FH
mutants and as fusions with the 4a zinc-finger gene. Digestion products are
shown. U, uncut; Hp, HpaII; Ms, MspI; Hh, HhaI restriction enzymes. (B)
SDS–PAGE analysis of purified recombinant zinc-finger–Mtase fusion
proteins, used for in vitro binding and methylation specificity studies.
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Materials and Methods for details). These zinc-ﬁnger proteins
were constructed both to test zinc-ﬁnger recognition code
validity and to generate targeted Mtase enzymes with differ-
ing afﬁnities for their target sites, so that the role of zinc-
ﬁnger DNA binding in targeted methyltransferase speciﬁcity
could be further assessed.
DNA-binding and methylation assays
Initial studies focused on puriﬁed GST fusion proteins
comprising various 4Zf proteins, fused to the HpaII FH
Mtase mutant. In addition to the 4a zinc-ﬁnger protein, 4b
and 4c zinc-ﬁnger proteins were designed to recognize the
sequences 50–30 GACGCGGCGCTC and TGGGGAGTG-
GCG, respectively. Puriﬁed zinc-ﬁnger HpaII Mtase proteins
(see Figure 1B) were used in gel shift assays to assess the
relative afﬁnities of the zinc-ﬁnger component of each fusion
protein. The results of titrative EMSAs are shown in
Figure 2A and B. Probe Ta comprises the 4a zinc-ﬁnger
and HpaII recognition sites, separated by 14 bp. Probe Tb/c
comprises a single HpaII site ﬂanked on either side by a
site for the 4b and 4c zinc-ﬁnger proteins, respectively.
Results conﬁrm high-afﬁnity binding of each fusion protein
only to probes harbouring the relevant recognition site, but
not to probes harbouring just the Mtase site, which bound
weakly. Analysis of these binding data revealed that the
4bFH Mtase protein binds most weakly to its target site
(apparent Kd   38 nM); the 4cFH Mtase protein binds most
strongly ( 3 nM). The 4aFH Mtase bound to its target site
with intermediate strength (Kd   11 nM) and similar to the
4a wild-type paII enzyme ( 9 nM). All enzymes bound to
just HpaII site-containing probe with a very low afﬁnity
that was not quantiﬁable under the conditions used, compared
with that seen for target site probe. Taken together, these
results conﬁrm previous observations made for three zinc-
ﬁnger Mtase fusions binding to target oligonucleotides that
binding is dominated by zinc-ﬁnger–DNA interactions (18).
Non-zinc-ﬁnger fusion wild-type HpaII (Figure 2B, left-
hand panel) bound signiﬁcantly more weakly to its target
site (Kd   170 nM, to HpaII DNA) than the targeted enzymes
to their target sites, but only slightly stronger to that seen for
targeted enzymes binding to HpaII site DNA. Much higher
protein levels were also used in this assay so that non-zinc-
ﬁnger wild-type and FH mutant protein binding could be
directly compared (Figure 2B, middle and right-hand panels).
Binding by the non-zinc-ﬁnger FH mutant was considerably
weaker than that seen for the wild-type non-zinc-ﬁnger
enzyme and could not be quantiﬁed. It was also signiﬁcantly
weaker than the observed binding of 4aFH to HpaII site
probe, with similar levels of complex formation observed at
non-fusion FH protein levels 50 fold higher than that of the
targeted enzyme, suggesting that the fusion protein as a
whole has an enhanced, albeit relatively weak, non-speciﬁc
interaction with DNA compared with just the Mtase compo-
nent alone. As we have noted before, however, differences in
the activity of these enzymes when expressed in bacteria, for
example (see Figure 1A), do not generally reﬂect the EMSA-
binding data, either as a consequence of differences in
catalytic rate and processive activity once bound to DNA or
due to local concentration and time-scale effects.
The methyltransferase characteristics of these proteins
were examined using in vitro and in vivo assays. Initial
analysis focused on the ability of the 4aFH protein to specif-
ically methylate at a simple target site, in comparison with
the non-targeted wild-type enzyme. Incubation of increasing
amounts of 4aFH Mtase or non-targeted M.HpaII enzyme
(NEB) with ZfM or M DNA, followed by a HpaII restriction
enzyme digest of these fragments, revealed the relative Mtase
activity of each protein for these different substrates. The
results are shown in Figure 2C. The non-targeted HpaII
wild-type enzyme was, as expected, unable to discriminate
between targeted and non-targeted HpaII site containing
DNA fragments, as evidenced by the similar resistance of
these DNA fragments to cleavage, as Mtase protein levels
are increased. The 4aFH Mtase enzyme, however, clearly
shows a preference for DNA which contains both zinc-ﬁnger
and adjacent HpaII sites, compared with DNA containing just
a HpaII site, denoted by the relatively early appearance of
DNA resistant to HpaII cleavage (arrowed in Figure 2C).
Presentation of these data in graphical form conﬁrms
similar gradients for the non-targeted wild-type enzyme
binding to either DNA fragment. A similar curve is seen
for 4aFH methylation of target site DNA. Methylation of
DNA containing just a HpaII site by this enzyme was how-
ever signiﬁcantly lower at lower levels of enzyme concentra-
tion, but with a rapid increase in methylation at higher protein
concentrations.
We next examined the ability of puriﬁed proteins to methy-
late at a targeted site against a complex background of
HpaII sites, using a plasmid-based assay. The plasmids
used contained a unique targetable sequence, comprising
adjacent zinc-ﬁnger and HpaII recognition sites, based essen-
tially on the Ta and Tb/c probes used previously. An addi-
tional 23 ‘background’ HpaII sites exist on these plasmids
within a 3.9 kb sequence and thus presents a signiﬁcant test
of targeting by these enzymes. Methylation at the target
site, followed by HpaII restriction of the plasmid, should
generate a unique restriction pattern indicative of targeted
methylation and give rise to a dominant unique band of
560 bp in size (see Figure 3A for schematic description of
this rationale). The results of this assay are shown in
Figure 3B. Puriﬁed four zinc-ﬁnger FH and 4aWT HpaII
Mtase proteins, as well as non-targeted HpaII wild-type
Mtase protein were incubated at increasing concentrations
with plasmids harbouring a targetable HpaII site either for
the 4aFH Mtase (plasmid Ta, left panels) or 4bFH and
4cFH Mtase proteins (plasmid Tb/c, right panels). After the
reaction was stopped, the plasmids were restricted with
rHpaII. Immediately apparent in some instances is the appea-
rance of a dominant intense band which is of the predicted
size, shown using arrows in the relevant panels. This occurs
only when the plasmid contains the appropriate target recog-
nition site. This is most noticeable for the 4cFH and 4aFH
protein which also show low background methylation.
The 4bFH enzyme gives the weakest evidence of targeted
methylation and displays a non-speciﬁc background methyla-
tion similar to that seen for targeted and non-targeted
wild-type enzyme. Generally, all the targeted FH proteins
displayed an approximately equivalent low level of non-
speciﬁc methylation in the absence of a target site. This
was more apparent when higher concentrations of protein
744 Nucleic Acids Research, 2007, Vol. 35, No. 3Figure 2. (A) EMSA analysis of purified recombinant four zinc-finger–HpaII (F
35H) mutant Mtase fusion proteins (the 4a, 4b and 4c zinc-finger components of
each protein are described in the text), compared with recombinant non-zinc-finger fusion M.HpaII wild-type and FH proteins. Recombinant protein was titrated
against either a target site or non-target site containing probe, at 0.1, 0.3, 0.5, 1, 3, 5, 10, 30 and 50 fmol. Lane C is probe only. The target sites are given under the
relevant panels. (B) Binding of M.HpaII wild-type protein to HpaII site DNA at equivalent concentration range to (A) is shown in the left-hand panel. Non-zinc-
finger fusion M.HpaII wild-type and FH proteins were also used at 50-fold higher levels, so that some comparative evidence of binding by the HpaII FH protein
to HpaII site DNA could be seen (middle and right-hand panels). (The probe used was Tb/c). (C) Methylation analysis of 4aFH versus M.HpaII protein for target
and non-target site containing DNA fragments. Increasing amounts of each protein (25, 50, 100, 150, 250 and 350 fmol) were incubated with DNA fragments
(1.0 mg) containing just an HpaII site (M), or an HpaII site and flanking 4a zinc-finger recognition site (ZfM). Following incubation, the reaction was stopped and
DNA subjected to restriction with R.HpaII and products resolved by electrophoresis. The intensity of the uncut band was measured for each lane (AIDA software,
raytest, GmbH) and normalized against the end point intensity. These data are presented in graphical form in the right-hand panel.
Nucleic Acids Research, 2007, Vol. 35, No. 3 745Figure 3. (A) Schematic diagram of the basis for plasmid-based and in situ bacterial assays for targeted methylation. A detailed diagram of the target site (which
is embedded in the target site vector) is shown. Following either incubation of plasmid with recombinant targeted methyltransferases or isolation from bacteria
co-transformed with expression and target site vectors, plasmids were subsequently restricted with either HhaI or HpaII restriction enzyme and the digest
products were analysed on an agarose gel. In the absence of any methylation, restriction occurs at all sites and a standard fragment pattern is generated, which
includes fragments of x and y bp in size derived from cleavage at a, b and the target site, indicated by a filled lollipop. Where targeted methylation has occurred,
restriction at that site is blocked, thus modulating the normal restriction pattern by the generation of a unique band of predicted length (designated the target
band), of size (x + y) bp as indicated in the figure. As further confirmation, this ‘target fragment’ should restrict at the EcoRV restriction sites within the target
region. (B) Plasmid-based methylation analysis of targeted and non-targeted HpaII wild-type and FH mutant proteins. Linearly increasing amounts of purified
protein (20–100 fmol, in 10 fmol increments) were incubated with either target site or non-target site plasmids (1–2 mg). After HpaII cleavage, the restriction
products were analysed by gel electrophoresis. Arrows denote the appearance (or expected location for wild-type enzyme panels) of a DNA fragment
corresponding to 560 bp in size [(x + y) fragment in Figure 1B], denoting targeted methylation. M is a DNA marker mix (NEB, 100 bp + 1 kb ladders). Lane C
represents DNA digested in the absence of Mtase incubation. Plasmids were additionally restricted with EcoRV to confirm the identity of the 560 bp fragment. A
typical result is shown for the 4aFH protein (centre panel).
746 Nucleic Acids Research, 2007, Vol. 35, No. 3were used but again, was proportionally and signiﬁcantly less
than that seen for the targeted wild-type enzyme (data not
shown). Conﬁrmation that the 560 bp band was indeed
derived from targeted methylation was shown by further
restriction of plasmids with EcoRV. This site is uniquely
present immediately ﬂanking the zinc-ﬁnger recognition
sites in each plasmid (see Figure 3A) and the targeted
methylation-derived band is cleaved as expected (shown for
the 4aFH protein in Figure 3, central panel). The identity of
this band was also initially conﬁrmed by sequencing. Signiﬁ-
cantly, the 4aWT protein gave a methylation proﬁle similar to
that of non-targeted HpaII enzyme under these conditions,
although a small degree of targeted methylation was observed
against a high background of non-speciﬁc events.
Bacterial in vivo analysis of targeted HpaII enzymes
The ability of mutant enzymes to speciﬁcally methylate at a
single targetable HpaII site on a plasmid in vitro, coupled
with the observation that respective expression vectors were
not methylated when isolated from E.coli, suggested to us
that we could develop an in vivo bacterial-based assay
for the detection of targeted methylation by this class of
enzyme. The assay comprises co-transformation of E.coli
with a compatible expression vector harbouring the targeted
methylase protein and the relevant target site vector,
followed by plasmid isolation and restriction with the
relevant methylation-sensitive restriction enzyme. As in the
case with in vitro assays, a unique band should similarly
appear indicative of targeted methylation. In order to enable
visualization of the targeted methylation-derived restriction
fragment against the expected background of cleavage
products from both expression and target site vectors, new
target site vectors were constructed. These were designed to
produce larger DNA fragments as a consequence of targeted
methylation and subsequent restriction (designated Ta2 and
Tb/c2). Preliminary in vitro methylation analysis using
recombinant puriﬁed 4aFH and 4cFH proteins conﬁrmed
that both new target vectors were speciﬁcally recognized by
the respective protein (see Figure 4A). A unique fragment
of  1060 bp appears as expected (shown using arrows in
Figure 4A, target vector panels), and is destroyed by
combined HpaII and EcoRV restriction (shown for 4aFH,
top-middle panel in Figure 4A). A low level of non-speciﬁc
methylation is observed for the 4cFH protein with non-target
site vector, which is shown in brackets (panel Ta2,
Figure 4A).
Bacterial in vivo evaluation of this new vector system
was performed, initially using the 4cFH protein, which con-
sistently gave good levels of targeted methylation in
in vitro assays. Following co-transformation with expression
and target or non-target vectors, bacteria were grown
overnight and plasmids were isolated and digested with
rHpaII and in concert with EcoRV. Control experiments
involved use of expression vectors coding for the null activity
targeted Mtases which retain the same Mtase (and hence
restriction) site distribution as functional enzyme coding
vectors. When 4cFH was expressed in the presence of the
wrong target site vector (Ta2), the same restriction pattern
is seen as with the null activity mutant (Figure 4B, lanes
4cN+Ta2 versus 4cFH+Ta2). Expression with the correct
target site vector (Tb/c2), however, produces the expected
band (arrowed), which is further shown to be destroyed by
EcoRV. An additional higher molecular weight band, only
seen with the target site vector, is shown using asterisks in
Figure 4B and fails to disappear upon additional cleavage
with KpnI. This band is derived from methylation at the
most proximal 50 HpaII site to the target region (site ‘a’i n
Figure 3A), but with no methylation occurring at the target
site itself. A cluster of low molecular weight bands were
also observed, but again only in the presence of the target
site vector, and persisted after additional restriction (shown
using brackets in Figure 4B).
As a further test of this system, we analysed a six zinc-
ﬁnger FH Mtase fusion protein, 6aFH, the targeting compo-
nent of which was a tandem repeat of the Zif268 protein,
linked together by the canonical TGEKP linker sequence
previously described to be effective in enlarging zinc-ﬁnger
arrays (30). Such Zif268-based six zinc-ﬁnger proteins have
been shown to bind their recognition sequence with high
afﬁnity [Kds in the pM/fM range (30,31)], whereas four
zinc-ﬁnger proteins generally have binding constants in the
nM range (19,21). The target site for this six zinc-ﬁnger
protein was 50-cgcccacgctcgcccacgc-30, the underlined base
separating the two original zif268 recognition sites. We had
not been able to purify a sufﬁcient amount of this protein
for in vitro analysis, due largely to solubility issues, and
thus this protein was an ideal candidate for evaluation by
the ‘in vivo’ system. Figure 4C shows the results of this
assay. In this instance, the unique band indicative of targeted
methylation is strong and seen only with the target site vector
(Ta2). This band is destroyed by additional EcoRV restric-
tion. Interestingly, the intensity of the target band increases
when plasmids derived from older bacterial cultures were
examined (shown using arrow in Figure 4C, right panel).
Additional higher molecular weight bands were also found,
which also disappear upon cleavage with EcoRV and are
indicative of possible processive action from the target site
(shown using bracket in Figure 4C, right-hand panel). A
similar effect was seen when freshly co-transformed cells
were grown under conditions in which expression of targeted
enzyme was induced (data not shown).
Bacterial in vivo analysis of targeted HhaI enzymes
We further used the bacterial in vivo system to evaluate the
4aHhaI Q
237 to G/V and I series of mutants for their relative
abilities to methylate speciﬁcally at the target site. The results
of this assay are shown in Figure 5A and suggest that only the
QG mutant gives speciﬁc targeted methylation under these
conditions. The unique band is shown using an arrow (left
panel), and destroyed upon additional EcoRV restriction as
expected. The QV, and QI mutants are less targeted in their
speciﬁcity, giving rise to an increasing background of non-
speciﬁc bands, respectively (non-speciﬁc methylation-derived
bands are shown using asterisks for the QV mutant), although
for the QV enzyme there is evidence of increased targeted
methylation. The 6aQG mutant gave evidence of targeted
methylation similar to that seen for 4aQG (see band arrowed
in Figure 5B, left panel). Transiently increasing the expres-
sion vector copy number relative to the target vector (using
DNA obtained directly from freshly transformed bacteria
Nucleic Acids Research, 2007, Vol. 35, No. 3 747Figure 4. (A) Plasmid-based methylation analysis of targeted and non-targeted HpaII wild-type and FH mutant proteins for ‘large fragment’ target vector.
Increasing amounts of purified 4aFH and 4cFH protein (as described in Figure 3) were incubated with target site or non-target site plasmids. After HpaII
cleavage, the restriction products were analysed via gel electrophoresis. Arrows denote the appearance of a DNA fragment corresponding to 1060 bp in size,
denoting targeted methylation. M is a DNA marker described previously. Bands derived from non-specific methylation are shown using brackets. (B) Bacterial-
based in vivo analysis of targeted methylation by 4cFH protein. Details are described in Materials and Methods. The left-hand panel shows the HpaII restriction
profile of the 4cNull and target vectors alone, and after co-isolation from bacteria, for comparative purposes. The right-hand panel shows the restriction profile of
4cFH after co-isolation with either target (Tb/c2) or non-target (Ta2) vector. The band indicative of targeted methylation is arrowed. Low molecular weight target
vector associated products are shown using brackets. A higher molecular weight product, just above the target band, resistant to KpnI cleavage, is shown using
asterisks. H, HpaII; V, HpaII + EcoRV; K, HpaII + KpnI restriction in all cases. (C) Bacterial-based in vivo analysis of targeted methylation by 6aFH protein.
Experimental details are essentially as in (B) above. The 1060 bp fragment indicative of targeted methylation is arrowed in the figure. The right-hand panel shows
the results of digestion of plasmids isolated from culture grown from 3-day-old bacterial colonies. The 1060 bp target band is arrowed. Higher molecular weight
bands related to the targeted methylation event are shown using brackets.
748 Nucleic Acids Research, 2007, Vol. 35, No. 3before liquid culture) resulted in an increase in intensity of
the target band, as well as the generation of additional higher
molecular weight bands (short arrows in Figure 5B, right
panel) that disappeared upon further cleavage with EcoRV,
again indicative of processive Mtase action.
Effects of targeted methyltransferase expression on
genomic DNA methylation status
Genomic DNA isolated from bacteria expressing various
targeted Mtase enzymes was digested with appropriate
methylation-sensitive restriction enzymes (shown in
Figure 6A and C). The results of arbitrary primed PCR
(AP-PCR) analysis of the digest products are shown in
Figure 6B and D. The methodology of combining
methylation-sensitive restriction digest followed by non-
speciﬁc PCR of the digest product is an approach often
used for analysing subtle differences between methylation
patterns of different tissue and cancer types (32,33). Targeted
HhaI mutants demonstrated the same broad range of
functional activity on genomic DNA as they did from plasmid
restriction assays, although perhaps less marked (Figure 6A).
The trend of increasing non-speciﬁc Mtase activity of these
enzymes is mirrored in the AP-PCR proﬁles obtained,
which results in differences in product levels and pattern
generated from equivalent quantities of template. For
example, the 4aNull and 4aQG PCR proﬁles are broadly
similar in terms of band intensities and pattern, whereas the
4aQV and more noticeably the 4aQI proﬁles, which showed
moderate and high levels of non-speciﬁc activity, respec-
tively, in bacterial assays (see Figure 5A), are markedly
different (compare 4aNull and 4aQG lanes with 4aQV and
4aQI and especially 4aWt lanes in Figure 6B). Genomic
DNA isolated from bacteria expressing the 4aFH HpaII
mutant appeared fully restricted (Figure 6C). The AP-PCR
proﬁle between the 4aNull (HpaII) and 4aFH enzyme were
similar (Figure 6D), although the intensities of certain
bands varied between the two samples. These small differ-
ences were of about the same levels as seen between the
HhaI 4aNull and 4aQG experiments, rather than the larger
differences seen for the QV or QI mutants. This again
suggests that little non-speciﬁc genomic methylation had
occurred for these targeted enzymes.
Targeted methylation of an integrated sequence in
HeLa cells
Having generated enzymes which produce only very low
levels of non-speciﬁc methylation against a relatively com-
plex bacterial genome, we next employed these enzymes to
deliver de novo methylation to a speciﬁc locus in mammalian
cells. We constructed a cell line harbouring a stably inte-
grated plasmid which comprised 4aZf recognition sites adja-
cent to eight HpaII and three HhaI sites (see Figure 7C). We
have previously shown that this four zinc-ﬁnger protein as a
fusion with VP16 is able to bind chromatin in mammalian
cells and upregulate transcription from promoters harbouring
its recognition site (21). We elected to employ a short, deﬁned
target region containing a low number of methylatable
sites so that the likelihood of any endogenous de novo
Mtase action and subsequent cellular response would be
reduced, thus allowing a ‘clean’ assessment of methylation
by the transiently expressed targeted enzymes, but providing
us with the opportunity to monitor maintenance and spread of
methylation to ﬂanking CG sequences by endogenous
enzymes over time. The target cell line was transfected
with either empty expression vector, 4aFH or 4aQG expres-
sion vectors, or a vector expressing the 4bFH protein,
Figure 5. Methylation-sensitive restriction analysis of plasmids isolated from
bacteria transformed with 4aHhaI or 6aHhaI expression vectors and target
vector [Ta2(HhaI)]. Experimental details are essentially as in Figure 4B. (A)
Restriction analysis of 4aQ
237HhaI mutant or null vectors and 4aHhaI-
specific target vector isolated from co-transformed bacteria. The 940 bp band
denoting targeted methylation for 4aQG is shown using an arrow. Evidence of
non-specific methylation by the 4QV mutant is shown using asterisks. (B)
Left-hand panel shows the results of the bacterial assay described above, for
the 6aQG protein. The band denoting targeted methylation is indicated (white
arrow). The non-specific band is shown using an asterisk. The right-hand
panel shows the effects of a transient increase in 6aQG expression vector
copy number on the intensity of the 940 bp band and the appearance of higher
molecular weight, targeted methylation related bands that disappear upon
EcoRV cleavage (small arrows). Low molecular weight non-specific bands
are shown using bracket. H, HhaI; V, HhaI + EcoRV restriction, throughout
this figure. M is marker mix, Kb is 1 kb ladder (NEB).
Nucleic Acids Research, 2007, Vol. 35, No. 3 749which does not recognize the target site (see Figure 7A for
general vector schematic and 7B, upper panel, for protein
expression). Western analysis indicated that the expression
of targeted Mtase enzymes was undetectable at day 6 (data
not shown). More sensitive RT–PCR analysis conﬁrmed com-
plete loss of Mtase expression at 12 days post-transfection.
An approximate 95% reduction in targeted Mtase RNA levels
was observed at only 6 days post-transfection, suggesting that
cellular mechanisms were responsible for perpetuating the
de novo methylation pattern at this stage (Figure 7B, lower
panel). Bisulphite sequencing of the genomic DNA isolated
from each experiment 14 days post-transfection is shown
in Figure 7C. Cells transfected with empty vector did not
become signiﬁcantly methylated over the course of the
experiment, conﬁrming that the CpG sequences associated
with the target site were not subject to methylation by the
endogenous methyltransferases. We were therefore able to
eliminate contributions from endogenous de novo activity in
our assessment of targeted methylation.
Methylation was only observed to a signiﬁcant extent when
the 4aFH enzyme was expressed in these cells. Only 3 of the
12 clones sequenced for this experiment were devoid of
methylation, 7 of the remaining 9 were methylated exten-
sively. Signiﬁcantly, the pattern of methylation found within
the target site varies, conﬁrming that our analysis was derived
from a number of different PCR clones. Most methylation
was observed 30 to the zinc-ﬁnger recognition site, a result
not unexpected due to the orientation of the zinc-ﬁnger
motif when bound to DNA and to the Mtase being fused at
the C-terminus. A few non-HpaII sites were observed to be
methylated within the target site and at some CpG sites in
ﬂanking regions, suggesting a low level of de novo methyla-
tion by endogenous enzymes. A low density and sporadic
pattern of methylation was observed with the 4bFH enzyme,
predominantly at HpaII sites. However, the level of methyla-
tion observed was signiﬁcantly lower than that seen for 4aFH,
conﬁrming zinc-ﬁnger interaction with DNA as the dominant
targeting event for the 4aFH enzyme.
Figure 6. Analysis of genomic DNA from bacteria expressing targeted methyltransferase enzymes. (A) Restriction analysis of genomic DNA recovered from
bacteria expressing various 4aHhaI enzyme derivatives (and containing the target site vector), described above the relevant lanes. The lane denoted ‘Con’
represents genomic DNA isolated from untransformed bacteria. U, uncut; C, cut with HhaI restriction enzyme. (Fragments seen in some ‘cut’ lanes are derived
from plasmid carryover during genomic DNA preparation, shown using arrows. Input genomic DNA is shown using asterisks.) (B) Arbitrary primed PCR of the
HhaI restricted genomic DNA described in (A). (C) Restriction analysis of genomic DNA recovered from bacteria expressing various 4aHpaII enzyme
derivatives, described above the relevant lanes. pWt is plasmid DNA coding for the wild-type targeted enzyme. U, uncut, C, cut with HpaII. (D) Arbitrary primed
PCR of HpaII restricted genomic DNA described in (C). M is 1 kb ladder (NEB), 100bp is 100 bp ladder (NEB).
750 Nucleic Acids Research, 2007, Vol. 35, No. 3Figure 7. (A) Schematic diagram describing mammalian vectors used for the expression of targeted Mtases. (B) Upper panel showing western blot confirming
expression levels of 4aFH, 4bFH and 4aQC targeted Mtase enzymes from vector described in (A). Lower panel showing the results of RT–PCR of 4aZfFH RNA
at 3, 6 and 12 days post-transfection with 4aZfFH targeted Mtase expression vector. b-Actin was used an internal control. PCR was performed for 28, 30, 32 and
34 cycles. (C) Bisulphite sequencing results for genomic target site DNA, 14 days post-transient transfection with targeted Mtase or control vector. The target site
sequence is given at the top of the figure. HpaII sites are in boldface and the 12 bp zinc-finger recognition site is boxed. Below this is a schematic diagram
showing target site and flanking CpG site distribution (represented by circles in sequencing data) spanning  160 bp. Large ticks indicate HpaII sites, small ticks
indicate HhaI sites. Zinc-finger recognition sites for the 4aZf protein are represented by filled rectangles. The expression vector transiently transfected in each
experiment is indicated next to each sequencing results block. Filled circles indicate observed methylation.
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Initial analysis showed that wild-type methyltransferases are
not targetable, producing unacceptably high levels of
background methylation when expressed as fusions with the
zinc-ﬁnger proteins used in this study. Binding analysis of a
series of different zinc-ﬁnger proteins fused with the HpaII
FH mutant showed the expected recognition speciﬁcity as
well as variations in afﬁnity for their respective sites. This
represents a general conﬁrmation of the accuracy of current
zinc-ﬁnger DNA recognition code information.
Signiﬁcantly, comparative analysis of the targeted 4aFH
and non-targeted M.HpaII methyltransferase enzymes for
methylating DNA fragments containing either single HpaII
sites or with a ﬂanking zinc-ﬁnger recognition site, revealed
that the 4aFH protein was largely target-site speciﬁc. Its
interaction with DNA was dominated by the zinc-ﬁnger
component, whereas the M.HpaII enzyme methylated all
DNA sequences equally. The degree of methylation achieved
by the 4aFH enzyme for target site DNA was also roughly
equivalent to that generally seen for the non-targeted wild-
type enzyme, suggesting that the lower catalytic afﬁnity of
the 4aFH Mtase component is being compensated for by
targeting of the Mtase at or near the targeted HpaII site,
to the extent that non-targeted methylation is virtually zero
for the 4aFH enzyme under conditions where targeted methy-
lation is relatively strong. As we have observed previously,
however, at excessive protein concentrations non-speciﬁc
Mtase activity is observed to some degree for all enzymes
studied, either as a consequence of increased non-speciﬁc
zinc-ﬁnger–DNA interactions (21), or due to high local
protein concentrations that compensate for the low activity/
afﬁnity attributes of the Mtase component. It should be
noted however that targeted mutant enzymes can be used at
much higher concentrations than targeted wild-type enzymes,
before non-targeted methylation becomes an issue.
Methylation analyses of more complex sequences, where
the target site represented only 4% of all HpaII sites present,
revealed a trend similar to that seen in gel shift assays. The
most signiﬁcant aspects of this assay are the observation of
speciﬁc targeted methylation in all cases, albeit variable,
except for the M.HpaII and 4aHpaII WT enzymes. There
was also a general lack of signiﬁcant non-speciﬁc methyla-
tion when the non-target site vector was used, again except
for M.HpaII and 4aWT enzymes. When the target site vector
was used, however, all targeted enzymes displayed evidence
of low methylation at a number of other sites to varying
degrees, implying such methylation is derived from the initial
targeted binding event in each case. Whether this is due to
plasmid topology, for example, or due to variable effects of
zinc-ﬁnger–DNA-binding afﬁnity on methyltransferase pro-
cession and/or dissociation is unclear at this time.
Evaluation of the 4cFH enzyme using the bacterial in vivo
assay system conﬁrmed the targeted methylation also
observed in in vitro plasmid-based assays. The increased
intensity of non-speciﬁc methylation of target site vector
relative to the ‘target band’ and to that seen in in vitro results
again suggests that plasmid topology may play a role in
bringing the targeted enzyme closer to non-targeted HpaII
sites, similar to the effects of nucleosome formation in mam-
malian cells. Evidence for targeted methylation-derived
events that did not include methylation at the target site itself
was also seen for the 4cFH enzyme, as evidenced by the
appearance of a slightly higher molecular weight band than
the target band, which was cleaved by EcoRV, but not cut
by KpnI. This effect was not seen in in vitro assays, again
suggesting that plasmid topology may be a factor in the
methylation of these vectors in vivo.
Similar in vivo analysis of the 6aFH protein in bacteria
revealed a high degree of targeting with no real evidence of
non-targeted methylation. Analysis of the longer term effects
of protein expression revealed that targeted methylation had
become more pronounced, with evidence of procession of
Mtase activity from the target site to the nearest ﬂanking
HpaII sites. This suggests that even with the expected build
up of protein within the cell over time, it still falls within
the range that allows monofunctionality of the enzymes.
Evidence of processive activity seemed less pronounced for
the 6aFH than four ﬁnger derivatives which were also studied
(data not shown), presumably due to tighter binding of the
former protein to its recognition sequence. Therefore for
targeted methylation purposes, it could be argued that four
zinc-ﬁnger derivatives would be more suitable for targeted
promoter methylation in mammalian cells, due to a relatively
higher processivity away from the initial binding site.
The general attributes of all the targeted FH mutants
examined in this study, correlate with studies of the F
18H
(homology and functionally related) mutation in M.HhaI,
which demonstrated a reduced catalytic activity for this
enzyme relative to the wild type, although no quantitative
assessment was made in that instance (27).
Analysis of the 4aHhaI mutants in bacterial assays demon-
strated variable levels of targeted methylation. Targeted
methylation by the 6aQG mutant was also evident. Similarly
to the time-dependent 6aFH HpaII action, evidence of proces-
sive methyltransferases activity from the initial binding site
was observed for this enzyme under conditions of transiently
increased protein concentration. While targeted methylation
was also seen to increase signiﬁcantly, background methyla-
tion rose proportionally. It therefore seems that as a general
rule, duration and level of expression of targeted methyltrans-
ferases in the cell may be key factors in controlling methyla-
tion delivery, non-speciﬁc action and potential processivity.
Variability in the activity of HhaI Q
237 mutants has been
observed previously for the M.HhaI protein and our choice
of mutants for this particular enzyme was largely based on
such studies. Methylation analysis of Q
237G/V and I mutants
revealed that these proteins had catalytic activities of 2.6%,
1.3% and 2.5%, respectively, of that of the wild-type enzyme
(28). Binding analysis in the same study revealed that the
Q
237G/V and I mutants bound to oligonucleotide substrates
with 0.1%, 0.1% and 3% of wild-type enzyme binding
afﬁnity, respectively. It has also recently been shown that
Q
237 may be involved in active ﬂipping of the target cytosine
from the DNA helix into the catalytic binding pocket of the
protein (34). In this study, substitutions of Q
237 with G and
A amino acids, all bound DNA, but no base ﬂipping was
observed. The QG mutant enzyme however does possess a
low but demonstrable methyltransferase activity in our
hands. This might suggest that base ﬂipping is actually still
occurring, but at a much slower rate than normal, and it is
only the anchoring of the methylase at or near its recognition
site due to zinc-ﬁnger tethering that allows the methyltransfer
752 Nucleic Acids Research, 2007, Vol. 35, No. 3reaction to proceed at a moderate level, before the enzyme
might ordinarily dissociate. This is corroborated to some
extent by the observation of a dramatically reduced exchange
of hydrogen atoms on the target cytosine base with protons
from water when DNA is bound by the Q
237G mutant (34).
Analysis of the effects of expression of various targeted
Mtases on the bacterial genome mirrors the activities seen
in in vivo bacterial-based plasmid assays, suggesting that
the latter method is sufﬁcient on its own to determine the
efﬁcacy of these enzymes.
Expression of the targeted 4aFH enzyme in mammalian
cells resulted in speciﬁc methylation of an integrated 4aZf-
speciﬁc target site at a signiﬁcantly higher level than that
seen for the control 4bFH enzyme, which was only a little
above the background level in these experiments. Given
that both 4aFH and 4bFH Mtases are broadly similar in
their non-speciﬁc methyltransferase activity, differences
between the two methylation patterns observed at the target
site can be attributed directly to zinc-ﬁnger targeting. A
strong methylation signal is maintained 14 days post-transient
transfection with the 4aFH vector, strongly suggesting that
the de novo methylation is being maintained by the cell, in
the absence of a measurable targeted Mtase presence. It is
perhaps surprising that no signiﬁcant methylation spread
was observed for this experiment, given the existence of
ﬂanking CpG sites around the target sequence and the action
of the endogenous Dnmt1 maintenance Mtase in maintaining
and possibly expanding methylation signals through
replication. However, this may simply reﬂect a time issue;
since, for example, in patients with myelodysplastic syn-
drome (MDS), where an initial low density of methylation
associated with tumour suppressor gene promoters is
observed, higher density methylation attributed to methyla-
tion spread is only seen with disease progression over rela-
tively long time scales (35). This may be similar to the
gradual process of gene silencing seen for the mouse Aprt
gene (36).
The 4aQG enzyme’s inability to deliver methylation to the
target site in mammalian cells is not surprising, given that this
enzyme was not very active in bacterial assays. The activity
associated with this enzyme may represent a threshold level,
only above which will these enzymes function to an observ-
able extent in mammalian cells and as such may serve as a
useful reference point for further studies.
In summary, we have developed enzymes in which the
dominant interaction with DNA is clearly driven by the
zinc-ﬁnger component. Moreover, the combination of strong
zinc-ﬁnger binding and reduced methyltransferase activity
gained from rational mutagenesis, has allowed us to target
methylation predominantly to speciﬁc DNA sequences
without incurring signiﬁcant background methylation. These
enzymes are fully functional in mammalian cells, where the
targeted methylation pattern delivered is demonstrated to be
inherited through successive cell divisions. The development
of targeted Mtase enzymes and methodologies to analyse
their function rapidly and within a relatively complex
model system, together with the further characterization
of their functional activity in vivo in mammalian cells, repre-
sents an important step towards the ultimate employment
of this class of molecule in both research and therapeutic
arenas.
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